Transforming growth factor (TGF)-b is stored in the extracellular matrix as a latent complex with its prodomain. Activation of TGF-b1 requires the binding of a v integrin to an RGD sequence in the prodomain and exertion of force on this domain, which is held in the extracellular matrix by latent TGF-b binding proteins. Crystals of dimeric porcine proTGF-b1 reveal a ring-shaped complex, a novel fold for the prodomain, and show how the prodomain shields the growth factor from recognition by receptors and alters its conformation. Complex formation between a v b 6 integrin and the prodomain is insufficient for TGF-b1 release. Force-dependent activation requires unfastening of a 'straitjacket' that encircles each growth-factor monomer at a position that can be locked by a disulphide bond. Sequences of all 33 TGF-b family members indicate a similar prodomain fold. The structure provides insights into the regulation of a family of growth and differentiation factors of fundamental importance in morphogenesis and homeostasis.
Transforming growth factor (TGF)-b is stored in the extracellular matrix as a latent complex with its prodomain. Activation of TGF-b1 requires the binding of a v integrin to an RGD sequence in the prodomain and exertion of force on this domain, which is held in the extracellular matrix by latent TGF-b binding proteins. Crystals of dimeric porcine proTGF-b1 reveal a ring-shaped complex, a novel fold for the prodomain, and show how the prodomain shields the growth factor from recognition by receptors and alters its conformation. Complex formation between a v b 6 integrin and the prodomain is insufficient for TGF-b1 release. Force-dependent activation requires unfastening of a 'straitjacket' that encircles each growth-factor monomer at a position that can be locked by a disulphide bond. Sequences of all 33 TGF-b family members indicate a similar prodomain fold. The structure provides insights into the regulation of a family of growth and differentiation factors of fundamental importance in morphogenesis and homeostasis.
The TGF-b family is key to specifying the body plan during metazoan development 1, 2 . Members of this family, including nodal, activins, inhibins, bone morphogenetic proteins (BMPs) and growth differentiation factors (GDFs), specify the anterior/posterior and dorsal/ ventral axes, endoderm, mesoderm and ectoderm, left-right asymmetry and details of individual organs. TGF-b1, TGF-b2 and TGF-b3 are important in development, wound healing, immune responses and tumour-cell growth and inhibition 1, 3 . Although TGF-b synthesis and expression of its receptors are widespread, activation is localized to sites where TGF-b is released from latency. TGF-b family members are synthesized with large aminoterminal prodomains, which are required for the proper folding and dimerization of the carboxy-terminal growth-factor domain 4 . Despite intracellular cleavage by furin, after secretion, noncovalent association persists between the dimeric growth-factor domain and prodomain of TGF-b, and of an increasingly recognized number of other family members. The prodomain is sufficient to confer latency on some family members and it also targets many members for storage in the extracellular matrix, in complex with latent TGF binding proteins (LTBPs) or fibrillins 5, 6 . The prodomains of TGF-b1 and TGF-b3 contain an RGD motif that is recognized by a v integrins. Mice with the integrin-binding RGD motif mutated to RGE recapitulate all major phenotypes of TGF-b1-null mice, including multi-organ inflammation and defects in vasculogenesis, thus demonstrating the essential role of integrins in TGF-b activation 7 . Among a v integrins, the phenotypes of integrin b 6 -null and integrin b 8 -null mice demonstrate the particular importance of the a v b 6 and a v b 8 integrins for activation of TGF-b1 and TGFb3 in vivo 8, 9 . Integrin binding alone is not sufficient for TGF-b activation. Activation by a v b 6 integrin requires incorporation of TGF-b1 into the extracellular matrix, by association with LTBP, and association of the b 6 cytoplasmic domain with the actin cytoskeleton 5, 10, 11 . Furthermore, contractile force is necessary for TGF-b activation by myofibroblasts 8 . Thus, tensile force exerted by integrins across the LTBP-prodomain-TGF-b complex is hypothesized to change the conformation of the prodomain and to free TGF-b for receptor binding 5, 8 . Here, we describe the structure of latent TGF-b, mechanisms for latency and integrin-dependent activation, and broad implications for the regulation of bioactivity in the TGF-b family.
Crystal structure
The structure of pro-TGF-b1 at 3.05 Å (Fig. 1a -c and Supplementary Table 1 ) was solved using multi-and single-wavelength anomalous diffraction. Electron density maps ( Supplementary Fig. 1 ) were improved by multi-crystal, multi-domain averaging over four monomers per asymmetric unit. In a ring-like shape, two prodomain arm domains connect at the elbows to crossed 'forearms' formed by the two growth-factor monomers and by prodomain 'straitjacket' elements that surround each growth-factor monomer (Fig. 1a-c and  4a ). The centre of the ring contains solvent. The arms come together at the neck, where they are disulphide-linked in a bowtie, and RGD motifs locate to each shoulder (Fig. 1a) . On the opposite side of the ring where the straitjacketed forearms cross, LTBP would be linked to straitjacket residue Cys 4, which is mutated to serine in the crystallization construct (Fig. 1a-c) .
The arm domain, residues 46-242, has a novel fold 12 with unusual features. Its two anti-parallel, four-stranded b-sheets bear extensive hydrophobic faces but these overlap only partially in the hydrophobic core (Fig. 1a, e) . The hydrophobic faces are extended by long meanders between the two sheets and burial by the a2, a3 and a4 helices.
b-strands b8 and b9 extend on the two-fold pseudo-symmetry axis to link the two arm domains in a bowtie at the neck (Fig. 1a) . The bow is tied with reciprocal inter-prodomain disulphide bonds, Cys 194-Cys 196 and Cys 196-Cys 194, and by hydrophobic residues (Fig. 1a, e) .
Arg 215 of the RGD motif locates to a disordered loop (residues 209-215) following the bowtie b9 strand. Partially ordered Gly 216 and Asp 217 of the RGD motif (Fig. 1a, d ) begin the long, 12-residue meander across the hydrophobic face of the neck-proximal b-sheet that connects to b10 in the forearm-proximal b-sheet.
The straitjacket, residues 1-45, is formed by the a1 helix and the latency lasso (Fig. 1a-c and 2a) . The latency lasso, an extended loop that connects the a1 and a2 helices, has little contact with the remainder of the prodomain while encircling the tip of each TGF-b monomer (Fig. 1a, b, f) . Six proline residues and three aliphatic residues make hydrophobic contacts with an extensive array of growth-factor aromatic and aliphatic residues, and help these to stabilize the conformation of the latency lasso (Fig. 1f) .
A highly hydrophobic face of the amphipathic a1 helix, bearing isoleucine and leucine residues, interacts with Trp 279 and Trp 281 and with aliphatic side chains on one growth-factor monomer (Fig. 1f , Fig. 2 and Supplementary Fig. 2 ), conserved a2-helix residues that interact with the growth factor are in pink, fastener residues are in silver and bowtie residues are in light green for aliphatics and yellow for Cys. f-h, Straitjacket and fastener details.
RESEARCH ARTICLE g). The tryptophan residues are further covered by lasso residues Leu 30, Pro 33 and Pro 34 (Fig. 1f) . Notably, the a1 helix is buried deeply in an interface between the two growth-factor monomers (Fig. 1a, b, g ). The interface on the second monomer includes three tyrosine residues (Fig. 1g) .
Together with the straitjacket, the arm domain completes the encirclement of each growth-factor monomer. The a2 helix buries Val 338 and Val 347 of the TGF-b finger (Fig. 1f) . The a5 helix projects from the base of the arm domain (Fig. 1a and e) and in it, prodomain residue Arg 238 forms a salt bridge to Glu 348 in TGFb1 (Fig. 1f, h ). These two residues are invariant in proTGF-b1, proTGF-b2 and proTGF-b3 ( Supplementary Fig. 2 ).
The straitjacket is fastened to arm residues 74-76 (Fig. 1a, h) . A backbone hydrogen bond between the nitrogen of Ala 76 and the oxygen of Lys 27 caps the C-terminal end of the a1 helix (Fig. 1h) . Moreover, the carbonyl oxygen of Ala 76 forms a hydrogen bond to Arg 238 in the a5 helix (Fig. 1h) . Lys 27 is a key fastener residue. Its side chain forms a p-cation bond to the side chain of Tyr 74, a hydrogen bond to the backbone of Tyr 74, and hydrogen bonds to the backbone and sidechain of Ser 351 (Fig. 1h) . Van der Waals contacts between the bulky side chains of the fastener residues Lys 27, Tyr 74
and Tyr 75 also secure the straitjacket. Notably, Lys 27, Tyr 74 and Tyr 75 are invariant among TGF-b1, TGF-b2 and TGF-b3 (Supplementary Fig. 2 ). Fastening is reinforced by backbone hydrogen bonds between arm b1-strand residues 77 and 78 and growth-factor b-fingers, which join the prodomain and the growth factor in a superb-sheet (Fig. 1a) .
The TGF-b dimer forms the forearms, although TGF-b monomers have also been described as hand-like [13] [14] [15] (Fig. 3) . Each monomer has no hydrophobic core, aside from the cystine knot motif in which one disulphide passes between two polypeptide segments bridged by two other disulphides.
Prodomain-bound TGF-b1 differs markedly from previous TGF-b structures in both the orientation between monomers and the position of elements within monomers ( Fig. 3 and Supplementary Fig. 3 ). The Ca root-mean-squared deviations over all 112 residues are 7 Å , and 2 Å over the most similar 85 residues. The largest differences are imposed by the prodomain a1 helix. It occupies a similar position to the growth-factor a3 helix in mature TGF-b1 ( Supplementary Fig. 3) . Intercalation of the prodomain a1 helix between the growth-factor monomers reduces the total area buried between monomers from 850 Å 2 to 335 Å 2 . The large conformational changes in TGF-b1 are Latency lasso
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driven by an intimate interaction between the growth-factor and prodomain dimers, which buries a total area of 2,440 Å 2 .
Implications for biosynthesis
Folding and secretion of active TGF-b1 and activin A requires the coexpression of their prodomains 4 , whereas the TGF-b1 prodomain can be biosynthesized in the absence of the growth-factor domain 16 . These findings suggest that the C-terminal growth-factor domain folds either concomitantly with, or subsequently to, the N-terminal prodomain. The kinetics of biosynthesis of TGF-b1, activin and anti-Müllerian hormone are slow and for anti-Müllerian hormone, folding of the growth-factor domain is rate-limiting 17 . Regions of the prodomain that may be particularly important in templating the folding of the growthfactor domain include the b1 strand that forms a supersheet with the TGF-b fingers and the a1 and a2 helices, which pack against extensive hydrophobic interfaces on opposite sides of the growth-factor fingers (Fig. 1a, f, g ). Residues Ile 17, Ile 24, Leu 25 and Leu 28 in the a1-helix interface, and Leu 30 in the lasso interface (Fig. 1f, g ), have been specifically identified as important for TGF-b1 association 18 . The embrace of the fingers of each growth-factor monomer may complement the correct formation of the cystine knot and inter-monomer disulphide bonds in TGF-b. The structure of proTGF-b1 makes these disulphides accessible to disulphide isomerases during biosynthesis (Fig. 1b) .
A definitive assignment of which growth-factor and prodomain monomers derive from the same polypeptide chain is not possible because of intracellular cleavage by furin and lack of density for residues 243-249. However, cleavage is incomplete and the small amount of uncleaved proTGF-b that is present in protein preparations cocrystallizes with cleaved proTGF-b ( Supplementary Fig. 1d ), indicating that there is no major conformational change after cleavage. A long prodomain-growth-factor connection through the centre of the ring, spanning ,50 Å , would require substantial conformational change and would limit access to furin. Therefore, we have assigned the shorter ,30 Å connection, between the C terminus of the prodomain and the N terminus of the growth factor, located on the same side of the ring (for example, the magenta and gold spheres in Fig. 1a, b) .
This assignment indicates a swap in the growth-factor monomer that each prodomain monomer embraces, with the intimate interactions described above occurring between prodomains and growthfactor domains that are present on different polypeptide chains in the precursor in the endoplasmic reticulum (for example, the gold and green domains in Fig. 1) . Thus, the surface area buried between the growth-factor domains and prodomains of different precursor monomers (900 Å 2 ) is substantially larger than that within the same precursor monomer (370 Å 2 ) and adds substantially to the intermonomer interfaces of the growth factor (330 Å 2 ) and prodomain (600 Å 2 ). Swapping may be important in regulating the proportion of growth-factor heterodimers, which have unique functions in settings such as dorsoventral patterning 19 .
Complex with LTBP and activation
In the large latent complex, a single LTBP molecule is disulphidebonded to two proTGF-b monomers. We confirmed this unusual 1:2 
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stoichiometry by multi-angle light-scattering mass measurements of the complex with an LTBP fragment. The LTBP-crosslinking Cys 4 residues in each monomer (serines in our construct) are 40 Å apart (Fig. 1b) . Their linkage to LTBP will reinforce the straitjacket by fastening together the forearms (Fig. 1c) . The large 40 Å separation may represent a mechanism for preventing disulphide linkage between the two Cys 4 residues. In contrast, the two cognate cysteines in TGF-binding domain 3 of LTBP become linked to one another in the absence of complex formation. These cysteines are surface-exposed and surrounded by acidic residues that interact with proTGF-b (refs 20, 21) . In agreement with this, the straitjacket a1-helices bear basic residues (Fig. 1b) . Moreover, between the two prodomain a1-helices, a concave growth-factor surface that bears numerous hydrophobic residues, including proline and disulphide-linked cysteine, is available for interaction with LTBP (Fig. 1b) .
Negative-stain electron microscopy class averages of proTGF-b are in excellent agreement with our crystal structure (Fig. 4a and Supplementary Fig. 4) . A complex with an LTBP fragment that contains TGF-b-binding domains 3 and 4 and two intervening EGF domains shows no major conformational change in the proTGF-b moiety (Fig. 4b ). An additional density corresponding to the LTBP fragment is present on the periphery of the ring, as expected from our crystal structure, and causes the ring to lie at an angle to the substrate in some class averages (Fig. 4b , middle panel and Supplementary Fig. 4c ).
The RGD motifs in the shoulders of proTGF-b are highly accessible for integrin binding (Fig. 1a) . In contrast to many RGD motifs that are present in extended loops, the position of Asp 217 is stabilized by burial of Leu 218 and by a 218-131 backbone hydrogen bond (Fig. 1d) . Exposed hydrophobic side chains that are nearby on the body of the arm domain (Fig. 1d ) may increase affinity for integrins.
The integrin a v b 6 ectodomain, with a C-terminal clasp, formed complexes with proTGF-b1 in Ca 21 and Mg 21 that could be isolated by gel filtration, demonstrating unusually tight binding for an integrin (Fig. 4c-e and Supplementary Fig. 4a ). Different input ratios of proTGF-b1 and a v b 6 integrin yielded 1:1 (Fig. 4c) and 1:2 (Fig. 4d,  e) complexes. Binding to ligand stabilized extension of the integrin legs and the open conformation of the a v b 6 headpiece 22 (Fig. 4c, d and Supplementary Fig. 4d , e). Integrins were bound to proTGF-b at the interface between a large density, corresponding to the a v b-propeller domain, and a small density, corresponding to the b 6 bI domain, with their legs extending away from proTGF-b. The spacing between the binding sites on the ring seen by electron microscopy (40-50 Å ) was appropriate for that between the two RGDs in the crystal structure (45 Å ). No major conformational change in proTGF-b1 was apparent, even with two integrins bound (Fig. 4d) , and SDS-polyacrylamide gel electrophoresis (SDS-PAGE) confirmed the presence of TGF-b1 in the complex (Fig. 4e) . These biochemical and structural studies demonstrate that integrin binding to proTGF-b1 is not sufficient for release of TGF-b1, consistent with previous cell-biological assays 5, 8, 10 . The requirements of (1) attachment of proTGF-b through LTBP to the extracellular matrix; (2) integrin attachment to the cytoskeleton and (3) cellular contraction indicate that the generation of tensile force across proTGF-b1 is required for activation of TGF-b 5,8,10,11 . The structure enables the overall mechanism of TGF-b1 activation by applied force to be readily predicted (Fig. 1c) . Tensile force applied to the RGD motifs in the shoulders by a v integrins attached to the actin cytoskeleton will be resisted at the opposite end of the ring, where the Cys 4 residues in the straitjacket are disulphide-linked to LTBP, which is tightly associated with the extracellular matrix. Pulling force will be applied in the directions shown by red arrows in Fig. 1a .
The direction of the pulling force and fold topology strongly influence the unfolding pathway and resistance to force 23 . b-Sheet proteins are the most force-resistant and thus the arm domain will be the most force-resistant portion of the prodomain. Pulling against the RGD motif will be transmitted through the long meander to the b10 strand. Force transmitted from the Cys 4 residues through the straitjacket will be resisted by the b1 strand. The b1 and b10 strands are each parallel to applied force and adjacent in a b-sheet (Fig. 1) and are thus in the most force-resistant structural geometry known, the hydrogen-bond clamp 23 . By contrast, the topologies and geometries of the a-helices and the long latency lasso of the straitjacket are ill-suited to resist force. Force on Cys 4 will apply leverage to the C-terminal end of the a1 helix and weaken interactions with fastener residues. After unfastening, the long latency lasso, which has no stabilizing hydrogen-bond interactions, will be easily elongated and straightened by the applied tensile force. Thus, freed by opening of its straitjacket, TGF-b will be released from the prodomain and activated for receptor binding (Fig. 1c) .
The prodomain not only holds TGF-b in a markedly different conformation from when it is free or bound to receptors, it also blocks receptor access completely. TGF-b family members are recognized by two type I receptors and two type II receptors that surround the growth-factor dimer ( Supplementary Fig. 3e ) 15 . Binding of the type II receptor to the finger-tips of the growth factor is blocked by the latency lasso, and binding of the type I receptor to the body of the growth-factor domain is blocked by the prodomain a1 helix, a5 helix, the fastener and the ends of b-strands 1, 3 and 10 ( Fig. 3) . Although straitjacket removal might be sufficient to allow binding of type II receptors, type I receptor interactions overlap with so many interactions between TGF-b and the arm domain (Fig. 3 ) that complete release from the prodomain would be required for receptor binding. The structure thus shows that integrins could not expose TGF-b sufficiently for receptor activation if it remained bound to the prodomain, and that other explanations should be sought for the greater activity of integrin-activated TGF-b on neighbouring cells than on distant cells 10 . To test the importance of unfastening in TGF-b activation, key residues were mutated. Non-conservative substitutions of the fastener residues Tyr 74 and Tyr 75 resulted in spontaneous, non-integrindependent TGF-b activation (Fig. 4f) . Among the different amino acids to which Tyr 74 and Tyr 75 were mutated, only phenylalanine was not activating. As a control, mutation of nearby Leu 28, in a hydrophobic interface with TGF-b, was not activating (Fig. 4f) . These results are consistent with the importance to fastening of p-bonding and of van der Waals interactions of the aromatic tyrosine side chains.
In the fastener, the Ca carbons of Lys 27 and Tyr 75 are only 4.1 Å apart, permissive for disulphide bond formation in a K27C/Y75C mutant, as confirmed by free-cysteine labelling of the Y75C mutant but not the K27C/Y75C mutant (Fig. 4h, i) . The K27C mutation greatly reduced expression (Fig. 4h) . Similarly, a K27A mutation greatly reduces expression, and also releases free TGF-b1 (ref. 18 ). The Y75C mutant was constitutively active (Fig. 4f) . The K27C/Y75C double mutation rescued expression compared to K27C, prevented the spontaneous release of TGF-b that was seen with Y75C and, compared to wild type, made proTGF-b completely resistant to integrina v b 6 -dependent activation (Fig. 4f, h ). Denaturants such as heat can unfold proteins by pathways distinct from applied force 23 . Heat released comparable amounts of active TGF-b from wild type and the K27C/ Y75C mutant (Fig. 4g) . Thus, a disulphide bond can fasten the straitjacket permanently and prevent integrin-dependent activation. These results support the hypothesis that tensile force applied to the prodomain by integrins can release TGF-b, and emphasise the importance of straitjacket unfastening in integrin-dependent activation.
Mutations in disease
Camurati-Engelmann disease (CED), which is characterized by thickening of the shafts of the long bones with pain in muscle and bone, is caused by mutations in the prodomain of TGF-b1 that increase its release 18, 24 . Among CED mutations, Y52H disrupts an a2-helix residue that cradles the TGF-b fingers (Fig. 1a, f) . The charge-reversal E140K and H193D mutations disrupt a pH-regulated ARTICLE RESEARCH salt bridge between Glu 140 and His 193 in the dimerization interface of the prodomain (Fig. 1a) . 'Hotspot' residue Arg 189 is substantially buried: it forms a cation-p bond with Tyr 142 and salt bridges across the dimer interface with bowtie residue Asp 197 (Fig. 1a) . Moreover, CED mutations in Cys 194 and Cys 196 demonstrate the importance of the bowtie disulphide bonds.
Implications for the large TGF-b family
The TGF-b family consists of 33 members (Fig. 2b) 2 . Although growth-factor domains are highly conserved, prodomains vary in length from 169 to 433 residues, and are variously described as unrelated in sequence or low in homology. However, alignment shows that all prodomains have a similar fold (Fig. 2a and Supplementary Fig. 2 ). Deeply buried hydrophobic residues in core secondary-structure elements of the arm domain, that is, the a2 helix and b-strands 1-3, 6, 7 and 10, are conserved in all members (gold side chains in Fig. 1e and orange circles in Fig. 2 and Supplementary Fig. 2 ).
Most family members also contain clear sequence signatures for the amphipathic C-terminal portion of the a1 helix that inserts intimately between the two growth-factor monomers ( Fig. 2 and Supplementary  Fig. 2) . A similar insertion in inhibin-a and inhibin-bA has been demonstrated by mapping disruptive mutations to the equivalents of Ile 24 and Leu 28 in TGF-b (Fig. 1f, g ) 25 . Many family members also contain proline-rich latency lasso loops with lengths that are compatible with encirclement of the growth-factor b-finger ( Fig. 2 and Supplementary Fig. 2 ). Thus, a prodomain structure similar to that of proTGF-b, including a portion of the straitjacket, is widespread in the TGF-b family. However, the low sequence identity and many insertions and deletions indicate substantial specializations.
Differences in prodomain dimerization among family members are indicated by variations in cysteine positions. The bowtie (b-strands 8 and 9) and its disulphides are specializations. Inhibin-a and -b subunits have cysteines in similar positions, whereas other family members either have cysteine residues in the b7 strand or lack cysteines altogether in this region ( Fig. 2 and Supplementary Fig. 2) .
The interface between the two arm domains in the b4 and b5 strands is modest in size and lacks hydrophobic and conserved residues. GDF1 and GDF15 specifically lack the b4 and b5 strands, which are adjacent in sequence and structure, on the edge of a b-sheet ( Fig. 1a and Supplementary Fig. 2) . Therefore, arm-domain dimerization seems to be variable or absent in some family members.
The close relatives of TGF-b, myostatin and GDF11, which are also latent, show conservation of the fastener residues Lys 27 and Tyr 75 ( Fig. 2a and Supplementary Fig. 2 ). Myostatin regulates muscle mass and is stored in the extracellular matrix, bound to LTBP3. Release of myostatin and GDF11 from latency requires cleavage of the prodomain between Arg 75 and Asp 76 by BMP1/tolloid metalloproteinases (reviewed in ref. 26 ). This cleavage is between the a2 helix and the fastener (Fig. 2a) . Thus at least two different methods of unfastening the straitjacket, force and proteolysis, can release family members from latency.
An increasingly large number of TGF-b family members are recognized to remain associated with their prodomains after secretion, including BMP4, BMP7, BMP10, GDF2, GDF5 and GDF8 (ref. 27 ). Furthermore, many of these prodomains bind with high affinity to fibrillin-1 and fibrillin-2. Targeting by the prodomain to the extracellular matrix may be of wide importance in regulating bioactivity in the TGF-b family 6 . Moreover, binding to LTBPs or fibrillins seems to strengthen the prodomain-growth-factor complex 6 . Thus, although only a limited number of TGF-b family members are latent as prodomain-growth-factor complexes, the concept of latency may extend to other members when their physiologically relevant complexes with LTBPs and fibrillins are considered.
The signalling range of BMP4 in vivo is increased by extracellular cleavage of the prodomain by furin-like proteases at a second site upstream of the prodomain-growth-factor cleavage site 28 . Notably, the second site is in the disordered loop bearing the arginine of RGD in TGF-b1 (Fig. 2a) . Loss of the central b10 strand between the two cleavage sites results in loss of binding of the BMP4 prodomain to its growth factor 27 . The prodomain of Nodal, which binds to Cripto, targets Nodal for cleavage by proteases secreted by neighbouring cells 29 . Anti-Müllerian hormone is secreted largely uncleaved and association with the prodomain greatly potentiates its activity in vivo 30 . Lefty protein, which is involved in establishing bilateral asymmetry, is not cleaved between the arm and growth-factor domains, and is cleaved instead between the a2 helix and the fastener 31 (Fig. 2) . Notably, release of the straitjacket should be sufficient to enable access of type II receptors to growth-factor domains.
Concluding perspective
We have described the structure of latent TGF-b1 and a force-dependent mechanism for its activation by a v integrins. It is notable that so many members of the TGF-b family associate with fibrillins or with LTBPs, which co-assemble in the elastic fibres of connective tissues 6 . Forces acting on elastic fibres would extend fibrillins and LTBPs, and we speculate that this could weaken their association with TGF-b family members, enabling release and activation. It is thus possible that forcedependent regulation of TGF-b family activation could extend beyond integrin-dependent mechanisms and could be important in a wide variety of contexts, including regulation of bone and tissue growth. Although prodomains in the TGF-b family are diverse, their sequences are highly conserved between species 2 . Further studies are required to address the diversity of mechanisms by which prodomains regulate latency and activation in the TGF-b family.
METHODS SUMMARY
Porcine proTGF-b1 with an N-terminal tag, C4S and N147Q mutations was expressed in CHO-Lec 3.2.8.1 cells. The protein was purified, treated with 3C protease to remove tags and then crystallized. Diffraction-quality crystals were obtained in 6.5-7.5% (w/v) polyethylene glycol 3500, 17-18% isopropanol, 4-5% glycerol and 0.1 M sodium citrate, pH 5.6. Structures were solved by Se multiwavelength anomalous dispersion and Hg single-wavelength anomalous dispersion. Maps were improved by multi-crystal averaging. The structure was built manually and refined to R work and R free factors of 27.4% and 31.1%, respectively. The a v b 6 ectodomain was expressed using C-terminal a-helical coiled-coils and tags, purified and subjected to negative-stain electron microscopy. TGF-b assays used 293T cells stably transfected with a v b 6 integrin and transiently transfected with mutant human proTGF-b1, then co-cultured with indicator cells expressing a luciferase gene under the control of a TGF-b1-inducible promoter.
METHODS
ProTGF-b1. The porcine proTGF-b1 construct with the rat serum albumin leader sequence (MKWVTFLLLLFISGSAFS), followed by eight histidine residues, a streptavidin-binding peptide (TTGWRGGHVVELAGELEQLRARLEHH PQGQREP) 32 and a HRV-3C protease site (LEVLFQGP) was amplified from pcDNA-GS-TGF-b1 (ref. 33) . Porcine proTGF-b1 with the C4S mutation was amplified from the latter construct. The C4S mutation increases proTGF-b1 expression 33 and avoids inappropriate disulphide bond formation 34 . No crystals were obtained with this construct. One or two N-linked sites were deleted in the N147Q and N107Q/N147Q constructs, which were expressed similarly to wild type 35 . The best crystals were obtained with N147Q; the N107Q/N147Q mutant yielded needles that could not be optimized. CHO-Lec 3.2.8.1 cells were transfected by electroporation and cultured with 10 mg ml 21 puromycin. Clones were screened for expression using a sandwich enzyme-linked immunosorbent assay (ELISA) with a capture antibody to prodomain-1 (R&D Systems) and a biotinylated detection antibody to the His tag (Qiagen). The clone with highest expression of proTGF-b1 (,2 mg l
21
) was expanded and cultured in roller bottles with J/J medium and 5% fetal bovine serum (FBS). Supernatants were collected every 5 d, clarified by centrifugation, concentrated tenfold with tangential flow filtration (Vivaflow 200, Sartorius Stedim), diluted fivefold with 10 mM Tris-HCl, 0.14 M NaCl (TBS, pH 8.0), then concentrated fivefold. Material was adjusted to 0.2 M NaCl and purified using Ni-NTA agarose (Qiagen) (25 ml per 5 l of culture supernatant), then washed with three column volumes of 0.6 M NaCl, 0.01 M Tris (pH 8.0) and eluted with 0.25 M imidazole in TBS. Material was adjusted to pH 7.4, applied to Strep-tactin agarose (IBA) (3 ml per 5 l of culture supernatant) and washed with TBS (pH 7.4). Then 4 ml of recombinant Histagged HRV-3C protease (Novagen, 100 U mg 21 , 1 mg ml 21 ), diluted 20-fold in TBS (pH 7.4) with 10% glycerol, was applied to the column, which was held at 4 uC for 16 h. The flow-through with two column volumes of TBS (pH 7.4), containing untagged proTGF-b1, was concentrated to 1 ml and applied to MonoQ and Superdex S200 columns connected in series and equilibrated with TBS (pH 7.5). Purified proTGF-b1 was concentrated to about 15 mg ml 21 in 10 mM Tris (pH 7.5), 75 mM NaCl for crystal screening in 96-well Greiner microplates (100 nl hanging-drop vapour diffusion format) using a mosquito crystallization robot (Molecular Dimensions) at 20 uC. Hits were optimized in 24-well plates using hanging-drop vapour diffusion. However, better-diffracting crystals could only be obtained from sitting drops containing equal volumes of 12-15 ml protein and well solution under the optimized conditions of 6.5-7.5% PEG 3500, 17-18% isopropanol and 0.1 M sodium citrate (pH 5.6), with the addition of 4-5% glycerol to slow crystal growth and improve crystal size and shape. Maximum single-crystal dimensions reached 450 mm 3 150 mm 3 40 mm. Before cooling the crystals to 100 K in liquid nitrogen, three rounds of increases in PEG 3350 concentration (12 h for each increase of 8% per cycle) were carried out in the mother liquor 36 . The final PEG 3350 concentration of about 31% was sufficient for cryoprotection. Crystals are summarized in Supplementary , giving a solvent content of 57.8%. To prepare Se-Met proTGF-b1, cells were washed with PBS (pH 7.4), supplemented with 1% FBS, then incubated for 8 h with methionine-free a-MEM (SAFC Biosciences) supplemented with 50 mg l 21 L-Se-Met (Sigma) and 10% dialyzed FBS. After replacement with the same medium, cells were cultured for 4 d. Se-Met proTGF-b1, at a yield of 1.5 mg l
, was purified and crystallized identically to native proTGF-b1. Furthermore, a heavy-atom derivative was obtained by soaking crystals in mother liquor containing 0.4 mM HgBr 2 for 4 h. Structure determination and refinement. Native Se multiple-wavelength anomalous dispersion (MAD) and single-wavelength anomalous dispersion (SAD) Hg derivative data were collected at 100 K at beamline 23-ID, then processed using HKL2000 (ref. 37 ) and XDS 38 . Statistics are in Supplementary Table 1 . Initial experimental phases were determined independently using Se-MAD and Hg-SAD, with 19 out of 24 Se sites and 14 Hg sites in the asymmetric unit located using PHENIX 39 . Electron density maps from Se-Met phasing, calculated after fourfold non-crystallographic symmetry (NCS) averaging, clearly defined the orientation of each monomer. The mature TGF-b1 homodimer was easily docked into the map using model 1KLC with MOLREP 40 in CCP4 (ref. 41 ). The prodomain was built into the map manually. A crude model of proTGF-b1 was obtained after rigid-body refinement by PHENIX, with both domains as one rigid body. The same model was docked into Hg-SAD density for the two homodimers, using MOLREP.
To improve the phases and extend them to higher resolution, multi-crystal averaging (two crystals in total: Se-MAD and Hg derivative), multi-domain averaging (with separate masks for each prodomain and TGF-b monomer) and solvent flattening and histogram matching were performed using DMMULTI 42 from the CCP4 suite. The mask for each domain was calculated by NCSMASK in CCP4, and NCS matrices for each domain between molecules and crystals were computed by LSQKAB in CCP4. Rigid-body refinements were carried out by PHENIX for each lattice, on the basis of the averaged maps. The new models for each lattice were then used to calculate a set of new NCS matrices for the next cycle of DMMULTI. These steps were cycled twice.
Model building in COOT 43 was based on multi-crystal, multi-domain averaged electron density maps and 2F o 2 F c maps. NCS restraints and translationlibration-screw (TLS) groups were used in refinement with PHENIX. The sequence-to-structure register was confirmed using Se anomalous maps. The multi-crystal, multi-domain averaging was repeated using the refined structure at an R free of about 33% and no major differences were found. Two residues from the 3C protease site remain at the N terminus after cleavage. The structures include residues 0-62, 70-208, 216-241, 250-361 and one N-acetylglucosamine (NAG) residue (chain A); residues 1-62, 70-208, 216-242, 250-299, 310-361 and two NAG residues (chain B); residues 1-62, 68-208, 216-241, 250-361 and three NAG residues (chain C) and residues 0-62, 69-208, 216-242, 250-361 and two NAG residues (chain D). Validation and Ramachandran statistics used MOLPROBITY 44 . All structure figures were generated using Pymol (DeLano Scientific).
In the asymmetric unit of the crystal, a second pro-TGF dimer extends each two-stranded b-ribbon to form a four-stranded, inter-dimer super-b-sheet in which Leu 203 forms a hydrophobic lattice contact. In its absence, Leu 203 may mediate hydrophobic interactions within the bowtie. Mutagenesis. Wild-type human proTGF-b1 was inserted into the pEF1-puro plasmid. Site-directed mutagenesis was performed using QuikChange (Stratagene). All mutations were confirmed by DNA sequencing. Free cysteine labelling and prodomain detection. HEK-293T cells were transfected using Polyfect reagent (Qiagen) according to the manufacturer's instructions, using 2 mg of proTGF-b1 cDNA per 6-cm dish of cells at 70-80% confluency. The cells were then cultured in FreeStyle serum-free medium (Invitrogen) for 3 d. Supernatant was reacted with 450 mM biotin-BMCC (1-biotinamido-4-(49-(maleimidoethylcyclohexane)-carboxamido)butane) (Pierce) for 60 min at 22u C, followed by the addition of 40 mM N-ethylmaleimide. ProTGF-b1 was immunoprecipitated with 1.5 mg anti-human-prodomain-1 (LAP-1) antibody (R&D Systems) and Protein A Sepharose beads (GE Healthcare) at 4 uC for 2 h, then subjected to reducing SDS 10% PAGE. After transfer to polyvinylidene difluoride membranes (Millipore), biotin was detected using streptavidin-horseradish peroxidase with the ECL-plus western blotting kit (GE Healthcare). Total proTGF-b1 was similarly detected on a separate blot using biotinylated human prodomain-1 (LAP-1) antibody. TGF-b1 activation assay. Transformed mink lung epithelial cells (TMLCs) stably transfected with a luciferase construct under plasminogen activator inhibitor promoter 1 (ref. 5) were provided by D. Rifkin (New York University). HEK-293T cell transfectants stably expressing a v and b 6 were selected with puromycin and G418. Clones expressing high levels of integrin a v b 6 were selected by immunofluorescent flow cytometry using an anti-b 6 antibody. Cells stably transfected with empty vector were used as a control. These cells were subsequently transiently transfected with human wild-type or mutant proTGF-b1, using lipofectamine with 0.4 mg plasmid DNA per well in a 48-well plate. After 16-24 h, each well was used to seed 3 wells of a 96-well plate with about 15,000 cells, which were cocultured with 15,000 TMLCs in 100 ml DMEM with 0.1% BSA for 16-24 h. TGFb1-induced luciferase activity in cell lysates was measured using the luciferase assay system (Promega). To assess heat-releasable TGF-b1, cells were transfected as above except that polyfect was used in 6-well plates. After 2 d, cells were collected and heated in 150 ml of DMEM with 0.1% BSA at 80 uC for 10 min. TGF-b1 activity in 50 ml aliquots was measured using the luciferase assay with TMLCs. Negative-stain electron microscopy. A large latent-complex fragment was isolated from supernatants of 293T cells transiently co-transfected with native human proTGF-b and a human LTBP fragment containing the same Nterminal tag as was used above on proTGF-b. The LTBP fragment contained the TB3 and TB4 domains and two intervening EGF-like domains (residues Thr 1333-Asn 1578, immature numbering). Multi-angle light scattering gave an M r of 119,400, compared to a calculated M r of 120,400 for a 2:1 proTGFb:LTBP fragment (2 3 46,400 for proTGF-b, including 2 3 7,500 for three high-mannose N-linked sites, plus 27,600 for the LTBP fragment). The a v b 6 ectodomain was expressed using C-terminal a-helical coiled-coils and tags; purified, then subjected to negative-stain electron microscopy as previously described 45 . Purified proTGF-b1 or proTGF-b1 in complex with an LTBP fragment (20 mg), proTGF-b1 (30 mg) in molar excess over clasped a v b 6 (20 mg), or clasped a v b 6 (60 mg) in excess over proTGF-b (10 mg) were subjected to Superdex S200 chromatography in TBS (pH 7.5) with 1 mM Ca 21 and 1 mM Mg 21 . Peak fractions corresponding to the purified proteins or complexes were subjected to RESEARCH ARTICLE
